List Of 2024 Biotech Ipos

List Of 2024 Biotech Ipos. Beyond those fundamentals, investors are eyeing specific areas within biotech, including oncology, autoimmune and cardio metabolic disease. (istock / getty images plus) coming off one of the worst.

Over the years, goodwin has been ranked among the top law firms for biotech ipos issuer representation. Cg oncology was quick out of the gates in the first week of 2024, becoming the first biotech to file for an ipo as the markets appeared poised for an upturn, and its stock popped.

In A Bullish Sign For The Us Biotech Ipo Market, Dozens More Life Sciences Companies Have Confidentially Filed, According To Advisers, Undeterred By The Poor.

As of jul 24, 2024, this is 20.69% more than the same time in 2023, which had 87 ipos by this date.

Emerging Biotechs Now Face A Tougher Road To Public Markets.

A run of offerings in the first six weeks of 2024, most worth around $100 million or more, has put the sector on its strongest pace since 2021.